Examination of 25-Hydroxyvitamin D Levels in Patients With Benign Positional Paroxysmal Vertigo

Year 2025, Volume: 7 Issue: 3, 768 - 73, 09.09.2025

Ersin Akçam , Özge Pınarbaşlı Akçam

Abstract

Aim: Benign paroxysmal positional vertigo (BPPV) is a prevalent cause of vertigo and dizziness. This study aimed to evaluate serum 25-hydroxyvitamin D [25(OH)-D] levels in patients diagnosed with posterior canal BPPV (PCBPPV) who presented to our clinic with dizzines complaints and healty induviduals without dizzines, and to investigate the association between low serum 25(OH)-D levels and BPPV.
Material and Method: Between January 2022 to March 2023, 50 patients (25 females, 25 males) with PCBPPV and 50 healthy controls (24 females, 26 males) without dizziness were enrolled. Serum 25(OH)-D levels of both groups were compared.
Results: Serum 25(OH)-D levels were significantly lower in the BPPV group compared to the control group (p=0.031). Serum 25(OH)-D levels were 20ng/mL or belowin 37 patients (74%) in the patient group (mean: 14.25±3.90), while this was observed in 28 induviduals (56%) in the control group (mean: 15.94±2.19).
Conclusion: Patients with BPPV exhibited significantly lower 25(OH)-D levels than healthy controls. These findings suggest that assessing vitamin D deficiency in BPPV patients may provide valuable insights into disease mechanisms and guide clinical management. Low 25(OH)-D levels appear to contribute to BPPV development.

Keywords

Benign positional paroxysmal vertigo , vitamin D deficiency , semicircular canals

Ethical Statement

The study was confirmed by the Scientific Research and Publication Ethics Comission of Afyonkarahisar Health Sciences University (dated 04.10.2024, decision no. 2024/8) and the institutional permission was obtained from Afyonkarahisar State Hospital, where the research personnel are actively employed (dated 02.08.2024).

References

• von Brevern M, Radtke A, Lezius F, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry. 2007;78:710-5.
• Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical practice guideline: benign paroxysmal positional vertigo (update). Otolaryngol Head Neck Surg. 2017;156:S1-47.
• Minasyan A, Keisala T, Zou J, et al. Vestibular dysfunction in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol. 2009;114:161-6.
• Shigeno K, Ogita H, Funabiki K. Benign paroxysmal positional vertigo and head position during sleep. J Vestib Res. 2012;22:197-203.
• İnan HC, Kıraç M. An evaluation of the effects of betahistine and dimenhydrinate on posterior canal benign paroxysmal positional vertigo. Turk Arch Otorhinolaryngol. 2019;57:191-6.
• Motin M, Keren O, Groswasser Z, Gordon CR. Benign paroxysmal positional vertigo as the cause of dizziness in patients after severe traumatic brain injury: diagnosis and treatment. Brain Inj. 2005;19:693-7.
• Neuhauser HK, Lempert T. Vertigo: epidemiologic aspects. Semin Neurol. 2009;29:473-81.
• Parnes LS, Agrawal SK, Atlas J. Diagnosis and management of benign paroxysmal positional vertigo (BPPV). CMAJ. 2003;169:681-93.
• Yang H, Zhao X, Xu Y, et al. Matrix recruitment and calcium sequestration for spatial specific otoconia development. PLoS One. 2011;6:e20498.
• Karataş A, Acar Yüceant G, Yüce T, et al. Association of benign paroxysmal positional vertigo with osteoporosis and vitamin D deficiency: a case controlled study. J Int Adv Otol. 2017;13:259-65.
• Jeong SH, Kim JS, Shin JW, et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol. 2013;260:832-8.
• Sheikhzadeh M, Lotfi Y, Mousavi A, et al. Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: a longitudinal clinical study. Caspian J Intern Med. 2016;7:93-8.
• Talaat HS, Kabel AM, Khaliel LH, et al. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx. 2016;43:237-41.
• Sreenivas V, Sima NH, Philip S. The role of comorbidities in benign paroxysmal positional vertigo. Ear Nose Throat J. 2021;100:NP225-30.
• Lin LY, Smeeth L, Langan S, Warren-Gash C. Distribution of vitamin D status in the UK: a cross-sectional analysis of UK Biobank. BMJ Open. 2021;11:e038503.
• Chakhtoura M, Rahme M, Chamoun N, El-Hajj Fuleihan G. Vitamin D in the Middle East and North Africa. Bone Rep. 2018;8:135-46.
• Jeong SH, Kim JS. Impaired calcium metabolism in benign paroxysmal positional vertigo: a topical review. J Neurol Phys Ther. 2019;43:S37-41.
• Büki B, Ecker M, Jünger H, Lundberg YW. Vitamin D deficiency and benign paroxysmal positioning vertigo. Med Hypotheses. 2013;80:201-4.
• Yang CJ, Kim Y, Lee HS, Park HJ. Bone mineral density and serum 25-hydroxyvitamin D in patients with idiopathic benign paroxysmal positional vertigo. J Vestib Res. 2018;27:287-94.
• Walther LE, Blödow A, Buder J, Kniep R. Principles of calcite dissolution in human and artificial otoconia. PLoS One. 2014;9:e102516.
• Maslovara S, Butkovic Soldo S, Sestak A, et al. 25 (OH) D3 levels, incidence and recurrence of different clinical forms of benig paroxysmal positional vertigo. Braz J Otorhinolaryngol. 2018;84:453-9.
• Talaat HS, Abuhadied G, Talaat AS, Abdelaal MS. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol. 2015;272:2249-53.
• Shin HI, Park Y, Lee HJ, Jeon EJ. Correlation between serum vitamin D level and benign paroxysmal positional vertigo recurrence. Auris Nasus Larynx. 2023;50:700-7.
• Sahni D, Kaur A, Bhagat S, et al. Correlation between vitamin D deficiency and benign paroxysmal positional vertigo. Natl J Physiol Pharm Pharmacol. 2022;12:2011-6.
• Pecci R, Mandalà M, Marcari A, et al. Vitamin D insufficiency/deficiency in patients with recurrent benign paroxysmal positional vertigo. J Int Adv Otol. 2022;18:158-66.
• Chen J, zhang S, Cui K, Liu C. Risk factors for benign paroxysmal positional vertigo recurrence: a systematic review and meta-analysis. J Neurol. 2021;268:4117-27.
• zhu CT, zhao XQ, Ju Y, et al. Clinical characteristics and risk factors for the recurrence of benign paroxysmal positional vertigo. Front Neurol. 2019;10:1190.
• Kim SY, Han SH, Kim YH, Park MH. Clinical features of recurrence and osteoporotic changes in benign paroxysmal positional vertigo. Auris Nasus Larynx. 2017;44:156-61.
• Parham K, Leonard G, Feinn RS, et al. Prospective clinical investigation of the relationship between idiopathic benign paroxysmal positional vertigo and bone turnover: a pilot study. Laryngoscope. 2013;123:2834-9.
• Güler İ, Baklacı D, Kuzucu İ, et al. Low serum 25-hydroxyvitamin D levels in patients with benign paroxysmal positional vertigo. KBB-Forum. 2018;17:35-9.